Unknown

Dataset Information

0

Genetic Modeling of B-cell State Transitions for Rational Design of Lymphoma Therapies.


ABSTRACT: The use of genomic data to analyze primary endpoints for clinical trials in diffuse large B-cell lymphomas (DLBCL) significantly improved the development of rational drug combinations for genetically defined patient subsets. Recent genetic mouse models and their ability to recapitulate transitions between germinal center exit and memory B-cell characteristics in DLBCL will accelerate the development of rationale-based clinical trials. See related article by Flümann et al., p. 78 (3). See related article by Venturutti et al., (5).

SUBMITTER: Leveille E 

PROVIDER: S-EPMC9816816 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genetic Modeling of B-cell State Transitions for Rational Design of Lymphoma Therapies.

Leveille Etienne E   Kothari Shalin S   Müschen Markus M  

Blood cancer discovery 20230101 1


The use of genomic data to analyze primary endpoints for clinical trials in diffuse large B-cell lymphomas (DLBCL) significantly improved the development of rational drug combinations for genetically defined patient subsets. Recent genetic mouse models and their ability to recapitulate transitions between germinal center exit and memory B-cell characteristics in DLBCL will accelerate the development of rationale-based clinical trials. See related article by Flümann et al., p. 78 (3). See related  ...[more]

Similar Datasets

| S-EPMC10946328 | biostudies-literature
| S-EPMC6943517 | biostudies-literature
| S-EPMC4580445 | biostudies-literature
2022-11-26 | GSE218774 | GEO
| S-EPMC5402386 | biostudies-literature
| S-EPMC9418002 | biostudies-literature
| S-EPMC8938425 | biostudies-literature
| S-EPMC9644236 | biostudies-literature
| S-EPMC6805649 | biostudies-literature
| S-EPMC7302387 | biostudies-literature